CIPREMI-100MG INJ. (REMDESIVIR)
₨ 6,399.73
CIPREMI is indicated for treatment of suspected or laboratory confirmed corona virus disease 2019 (COVID-19) in adults and children hospitalized with severe disease.
The dose of the drug for adult and pediatric patients weighing more than 40 kg should be a single dose of 200 mg infused intravenously over 30 to 120 minutes on day 1 followed by once daily maintenance dose of 100 mg, infused intravenously over 30 to 120 minutes for 4 days and the dose for pediatric patients with body weight between 3.5 kg and less than 40 kg should be single loading dose of 5 mg/kg IV infused over 30-120 minutes on day 1 followed by 2.5 mg/kg IV infused over 30-120 minutes once daily for 4 days. Extension of administration of drug beyond 5 days to 10 days is not recommended.
Reviews
There are no reviews yet.